Zago Wagner M. has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 190000 shares of PROTHENA CORP PUBLIC LTD CO ($PRTA) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Zago Wagner M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 190000 | $0.00 | 190,000.0000 | 53,830,000 | 9999.99% | 0.35% |
| July 28, 2025 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Zago Wagner M. | Chief Scientific Officer | A | Ordinary Shares, par value $0.01 per share | 85000 | $0.00 | 85,000.0000 | 53,772,000 | 9999.99% | 0.16% |
| March 5, 2025 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Zago Wagner M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 107500 | $0.00 | 107,500.0000 | 53,772,000 | 9999.99% | 0.20% |
| Feb. 27, 2024 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Zago Wagner M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 53,216,000 | 9999.99% | 0.16% |